<DOC>
	<DOC>NCT01028846</DOC>
	<brief_summary>The purpose of this study is to understand how diazoxide, a medication that has been shown to have effects on insulin and other hormone secretion, can regulate the production of sugar by the liver.</brief_summary>
	<brief_title>Central Mechanisms That Regulate Glucose Metabolism in Humans</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diazoxide</mesh_term>
	<criteria>BP &lt; 130/90 (+2 meds) BMI &lt; 35 Normal screening labs (CBC, chemistry, lft's PT/PTT) No CAD No first degree relatives with history of CAD or MI (men &lt; 45; women &lt; 55) Good IV access Noth other medical problems with exception: HTN (on &lt; or = 2 meds), hypercholesterolemia, and stable retinopathy Nonsmoker Hemoglobin A1C 7.511 BP&gt;130/90 (+ medications) BMI &gt; 35 Abnormal EKG History of CAD or exertional chest pain First degree relative with early CAD or MI Medications for medical or psychiatric conditions including: dofetilide, fosphenytoin/phenytoin trichlormethiazide (any thiazide), chlorpromazine and warfarin &lt; 4 week history of participation in another drug trial</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Type 2 Diabetes</keyword>
</DOC>